BIO
Financials
- Market Capitalization 9.79 B
- Employee 7 450
- Founded N/A
- CEO Norman David Schwartz
- Website www.bio-rad.com
- Headquarter Delaware, United States
- FIGI BBG000DY28W5
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 799 |  SNN Smith & Nephew SNATS Inc | 27.24 USD | +1.04% | +2.95% | -3.98% | -25.68% | 11.95 B USD | ||
| 895 |  GMED Globus Medical, Inc. Class A Common Stock | 74.66 USD | +1.76% | -1.48% | -1.05% | +30.87% | 10.02 B USD | ||
| 910 |  GKOS Glaukos Corporation Common Stock | 165.70 USD | +2.73% | +0.75% | -1.22% | +97.69% | 9.77 B USD | ||
| 928 |  PODD Insulet Corporation - Common Stock | 135.28 USD | +0.60% | +2.73% | +0.78% | -56.98% | 9.38 B USD |
Frequently asked questions about Bio-Rad Laboratories, Inc.Class A
What is the Bio-Rad Laboratories, Inc.Class A stock price today?
The current price of Bio-Rad Laboratories, Inc.Class A (BIO) is 366.22. Over the past 24 hours, the stock has changed by +1.65%. Follow the BIO chart for real-time price dynamics.
What is the stock ticker of Bio-Rad Laboratories, Inc.Class A?
Bio-Rad Laboratories, Inc.Class A trades under the ticker BIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bio-Rad Laboratories, Inc.Class A stock going up?
BIO has changed by -1.99% over the last week, +0.15% over the last month, and +8.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bio-Rad Laboratories, Inc.Class A?
Bio-Rad Laboratories, Inc.Class A currently has a market capitalization of 9.79 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Bio-Rad Laboratories, Inc.Class A earnings last quarter?
Last quarter, Bio-Rad Laboratories, Inc.Class A reported earnings of 13.89 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Bio-Rad Laboratories, Inc.Class A revenue for the last quarter?
Bio-Rad Laboratories, Inc.Class A reported quarterly revenue of 651 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Bio-Rad Laboratories, Inc.Class A net income for the last quarter?
Bio-Rad Laboratories, Inc.Class A reported net income of 371.4 M for the last quarter. The previous quarter showed -527.1 M, which means net income changed by +170.46%.
How many employees does Bio-Rad Laboratories, Inc.Class A have?
As of the latest available data, Bio-Rad Laboratories, Inc.Class A has 7 450 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bio-Rad Laboratories, Inc.Class A EBITDA?
Bio-Rad Laboratories, Inc.Class A EBITDA is 72.6 M, and its EBITDA margin is 11.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bio-Rad Laboratories, Inc.Class A stock?
You can buy Bio-Rad Laboratories, Inc.Class A (BIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bio-Rad Laboratories, Inc.Class A stock?
Investing in Bio-Rad Laboratories, Inc.Class A requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIO chart and related analysis on metatrader.com as part of your research.